يعرض 161 - 180 نتائج من 8,976 نتيجة بحث عن '(( 5 ppm decrease ) OR ((((( 50 nn decrease ) OR ( 50 μ decrease ))) OR ( 50 we decrease ))))', وقت الاستعلام: 0.95s تنقيح النتائج
  1. 161

    Evaluating the Potential of Ozone Microbubbles for Inactivation of Tulane Virus, a Human Norovirus Surrogate حسب Bozhong Guan (18598178)

    منشور في 2024
    "…After 2, 10, and 20 min postgeneration, the ozone concentration of microbubbles naturally decreased from 4 ppm to 3.2 ± 0.2, 2.26 ± 0.19, and 1.49 ± 0.23 ppm and resulted in 1.43 ± 0.44, 0.88 ± 0.5, and 0.68 ± 0.53 log<sub>10</sub> viral reductions, respectively, while the ozone concentration of aqueous ozone decreased from 4 ppm to 2.52 ± 0.07, 0.43 ± 0.05, and 0.09 ± 0.01 ppm and produced 0.8 ± 0.28, 0.29 ± 0.41, and 0.16 ± 0.21 log<sub>10</sub> reductions against Tulane virus, respectively (<i>p</i> = 0.0526), suggesting that structuring of ozone in the bubbles over the applied treatment conditions did not have a significant effect, though future study with continuous generation of ozone microbubbles is needed.…"
  2. 162

    Identification of druggable small molecule antagonists of the <i>Plasmodium falciparum</i> hexose transporter PfHT and assessment of ligand access to the glucose permeation pathway... حسب Monique R. Heitmeier (6686069)

    منشور في 2019
    "…WU-1 showed comparable potency in blocking 2-DG uptake in freed parasites and inhibiting parasite growth, with an IC<sub>50</sub> of 6.1 ± 0.8 μM and EC<sub>50</sub> of 5.5 ± 0.6 μM, respectively. …"
  3. 163
  4. 164
  5. 165
  6. 166
  7. 167
  8. 168
  9. 169

    Novel Antagonist of the Type 2 Lysophosphatidic Acid Receptor (LPA<sub>2</sub>), UCM-14216, Ameliorates Spinal Cord Injury in Mice حسب Nora Khiar-Fernández (8130210)

    منشور في 2022
    "…Inhibition of the type 2 lysophosphatidic acid receptor (LPA<sub>2</sub>) has recently emerged as a new potential pharmacological approach to decrease SCI-associated damage. Toward validating this receptor as a target in SCI, we have developed a new series of LPA<sub>2</sub> antagonists, among which compound <b>54</b> (UCM-14216) stands out as a potent and selective LPA<sub>2</sub> receptor antagonist (<i>E</i><sub>max</sub> = 90%, IC<sub>50</sub> = 1.9 μM, <i>K</i><sub>D</sub> = 1.3 nM; inactive at LPA<sub>1,3–6</sub> receptors). …"
  10. 170

    Novel Antagonist of the Type 2 Lysophosphatidic Acid Receptor (LPA<sub>2</sub>), UCM-14216, Ameliorates Spinal Cord Injury in Mice حسب Nora Khiar-Fernández (8130210)

    منشور في 2022
    "…Inhibition of the type 2 lysophosphatidic acid receptor (LPA<sub>2</sub>) has recently emerged as a new potential pharmacological approach to decrease SCI-associated damage. Toward validating this receptor as a target in SCI, we have developed a new series of LPA<sub>2</sub> antagonists, among which compound <b>54</b> (UCM-14216) stands out as a potent and selective LPA<sub>2</sub> receptor antagonist (<i>E</i><sub>max</sub> = 90%, IC<sub>50</sub> = 1.9 μM, <i>K</i><sub>D</sub> = 1.3 nM; inactive at LPA<sub>1,3–6</sub> receptors). …"
  11. 171
  12. 172
  13. 173
  14. 174
  15. 175

    Immunoblot images of α-SMA, PCNA and Sirt1. حسب Hanhan Liu (568151)

    منشور في 2024
    الموضوعات:
  16. 176
  17. 177
  18. 178

    Primers for real-time PCR (rat). حسب Hanhan Liu (568151)

    منشور في 2024
    الموضوعات:
  19. 179

    Raw image of western blots. حسب Hanhan Liu (568151)

    منشور في 2024
    الموضوعات:
  20. 180